![Page Background](./../common/page-substrates/page0146.jpg)
Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved.
The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.
MS-71
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
57. Gilleard O, Goodman A, Cooper M, et al. The significance of the
Van Nuys prognostic index in the management of ductal carcinoma in
situ. World J Surg Oncol 2008;6:61-61. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18564426.
58. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for
ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274.
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/8635094 .59. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of
margin width on local control of ductal carcinoma in situ of the breast. N
Engl J Med 1999;340:1455-1461. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/10320383.
60. Hughes LL, Wang M, Page DL, et al. Local excision alone without
irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern
Cooperative Oncology Group. J Clin Oncol 2009;27:5319-5324.
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19826126.
61. Wong P, Lambert C, Agnihotram RV, et al. Ductal carcinoma in situ-
the influence of the radiotherapy boost on local control. Int J Radiat
Oncol Biol Phys 2011. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21664063.
62. MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in
ductal carcinoma in situ treated by excision alone: incremental benefit of
larger margins. Am J Surg 2005;190:521-525. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16164913.
63. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on
local recurrence after breast conservation and radiation therapy for
ductal carcinoma in situ. J Clin Oncol 2009;27:1615-1620. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19255332.
64. Groot G, Rees H, Pahwa P, et al. Predicting local recurrence
following breast-conserving therapy for early stage breast cancer: the
significance of a narrow (</= 2 mm) surgical resection margin. J Surg
Oncol 2011;103:212-216. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21337549.
65. Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative
radiotherapy for ductal carcinoma in situ of the breast--a systematic
review of the randomised trials. Breast 2009;18:143-149. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19447038.
66. Waddell BE, Stomper PC, DeFazio JL, et al. Postexcision
mammography is indicated after resection of ductal carcinoma-in-situ of
the breast. Ann Surg Oncol 2000;7:665-668. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11034243.
67. Julian TB, Land SR, Fourchotte V, et al. Is sentinel node biopsy
necessary in conservatively treated DCIS? Ann Surg Oncol
2007;14:2202-2208. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17534687.
68. Cody HS, Van Zee KJ. Point: sentinel lymph node biopsy is
indicated for patients with DCIS. J Natl Compr Canc Netw 2003;1:199-
206. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19768878 .69. Edge SB, Sheldon DG. Counterpoint: sentinel lymph node biopsy is
not indicated for ductal carcinoma in situ. J Natl Compr Canc Netw
2003;1:207-212. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19768879.
70. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of
Clinical Oncology guideline recommendations for sentinel lymph node
biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16157938.
71. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the
prevention of breast cancer: current status of the National Surgical
Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst
2005;97:1652-1662. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16288118.